Ganoderic acid KCAS# 104700-95-0 |
2D Structure
Quality Control & MSDS
3D structure
Package In Stock
Number of papers citing our products
Cas No. | 104700-95-0 | SDF | Download SDF |
PubChem ID | 74036828 | Appearance | Powder |
Formula | C32H46O9 | M.Wt | 574.7 |
Type of Compound | Triterpenoids | Storage | Desiccate at -20°C |
Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
Chemical Name | 6-(12-acetyloxy-3,7-dihydroxy-4,4,10,13,14-pentamethyl-11,15-dioxo-2,3,5,6,7,12,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl)-2-methyl-4-oxoheptanoic acid | ||
SMILES | CC(CC(=O)CC(C)C(=O)O)C1CC(=O)C2(C1(C(C(=O)C3=C2C(CC4C3(CCC(C4(C)C)O)C)O)OC(=O)C)C)C | ||
Standard InChIKey | OEHYQHPDUCRLMW-UHFFFAOYSA-N | ||
Standard InChI | InChI=1S/C32H46O9/c1-15(11-18(34)12-16(2)28(39)40)19-13-23(37)32(8)24-20(35)14-21-29(4,5)22(36)9-10-30(21,6)25(24)26(38)27(31(19,32)7)41-17(3)33/h15-16,19-22,27,35-36H,9-14H2,1-8H3,(H,39,40) | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Description | 1. Ganoderic acid K has anti-tumor activity. 2. Ganoderic acid K has anti-inflammatory activity. 3. Ganoderic acid K is an angiotensin-converting enzyme inhibitor. |
Targets | Immunology & Inflammation related |
Ganoderic acid K Dilution Calculator
Ganoderic acid K Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 1.74 mL | 8.7002 mL | 17.4004 mL | 34.8008 mL | 43.501 mL |
5 mM | 0.348 mL | 1.74 mL | 3.4801 mL | 6.9602 mL | 8.7002 mL |
10 mM | 0.174 mL | 0.87 mL | 1.74 mL | 3.4801 mL | 4.3501 mL |
50 mM | 0.0348 mL | 0.174 mL | 0.348 mL | 0.696 mL | 0.87 mL |
100 mM | 0.0174 mL | 0.087 mL | 0.174 mL | 0.348 mL | 0.435 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Lupiwighteone
Catalog No.:BCN4045
CAS No.:104691-86-3
- Iriflophenone 3-C-beta-D-glucopyranoside
Catalog No.:BCN1635
CAS No.:104669-02-5
- 7,3'-Di-O-methylorobol
Catalog No.:BCN6831
CAS No.:104668-88-4
- H-Ile-NH2.HCl
Catalog No.:BCC2962
CAS No.:10466-56-5
- Dexpramipexole
Catalog No.:BCC1527
CAS No.:104632-28-2
- Dexpramipexole dihydrochloride
Catalog No.:BCC1528
CAS No.:104632-27-1
- Pramipexole
Catalog No.:BCC4467
CAS No.:104632-26-0
- Pramipexole dihydrochloride
Catalog No.:BCN2181
CAS No.:104632-25-9
- CGS 15943
Catalog No.:BCC7157
CAS No.:104615-18-1
- Caffeic acid phenethyl ester
Catalog No.:BCN2695
CAS No.:104594-70-9
- p-Menthan-3-one
Catalog No.:BCN3850
CAS No.:10458-14-7
- CAY10603
Catalog No.:BCC5542
CAS No.:1045792-66-2
- Ganoderol B
Catalog No.:BCN5859
CAS No.:104700-96-1
- Ganoderol A
Catalog No.:BCN5860
CAS No.:104700-97-2
- Ganoderal A
Catalog No.:BCN2451
CAS No.:104700-98-3
- Boc-D-Glu(OtBu)-OH
Catalog No.:BCC3395
CAS No.:104719-63-3
- 8-Phenyloctanol
Catalog No.:BCC8791
CAS No.:10472-97-6
- 6-O-α-Maltosyl-β-cyclodextrin
Catalog No.:BCC8075
CAS No.:104723-60-6
- Mayteine
Catalog No.:BCN3098
CAS No.:104736-05-2
- 4E-Deacetylchromolaenide 4'-O-acetate
Catalog No.:BCN7263
CAS No.:104736-09-6
- Ganoderic acid S
Catalog No.:BCN5861
CAS No.:104759-35-5
- Strontium chloride
Catalog No.:BCC7973
CAS No.:10476-85-4
- GSK2141795
Catalog No.:BCC5294
CAS No.:1047634-65-0
- GSK2141795 hydrochloride
Catalog No.:BCC5295
CAS No.:1047635-80-2
Effects of triterpenes from Ganoderma lucidum on protein expression profile of HeLa cells.[Pubmed:20092987]
Phytomedicine. 2010 Jul;17(8-9):606-13.
To elucidate the cytotoxicity mechanism of Ganoderma triterpenes, a chemoproteomic study using five purified ganoderic acids, ganoderic acid F (GAF), Ganoderic acid K (GAK), ganoderic B (GAB), ganoderic acid D (GAD) and ganoderic acid AM1 (GAAM1) was conducted. GAF, GAK, GAB, GAD and GAAM1 treatment for 48 h inhibited the proliferation of HeLa human cervical carcinoma cells with IC(50) values of 19.5+/-0.6 microM, 15.1+/-0.5 microM, 20.3+/-0.4 microM, 17.3+/-0.3 microM, 19.8+/-0.7 microM, respectively. The protein expression profiles of HeLa cells treated with each ganoderic acid at dose of 15 microM for 48 h were checked using two-dimensional electrophoresis (2-DE). The possible target-related proteins of ganoderic acids, i.e. proteins with same change tendency in all five ganoderic acids-treated groups compared with control, were identified using MALDI-TOF MS/MS. Twelve proteins including human interleukin-17E, eukaryotic translation initiation factor 5A (eIF5A), peroxiredoxin 2, ubiquilin 2, Cu/Zn-superoxide dismutase, 14-3-3 beta/alpha, TPM4-ALK fusion oncoprotein type 2, PP2A subunit A PR65-alpha isoform, nucleobindin-1, heterogeneous nuclear ribonucleoprotein K, reticulocalbin 1 and chain A of DJ-1 protein were identified. Ganoderic acids might exert their cytotoxicity by altering proteins involved in cell proliferation and/or cell death, carcinogenosis, oxidative stress, calcium signaling and ER stress.